share_log

Pyxis Oncology | SC 13G: Statement of acquisition of beneficial ownership by individuals-Deep Track Capital, LP(7.87%),Deep Track Biotechnology Master Fund, Ltd.(7.87%), etc.

Pyxis Oncology | SC 13G: Statement of acquisition of beneficial ownership by individuals-Deep Track Capital, LP(7.87%),Deep Track Biotechnology Master Fund, Ltd.(7.87%), etc.

Pyxis Oncology | SC 13G:超過5%持股股東披露文件-Deep Track Capital, LP(7.87%),Deep Track Biotechnology Master Fund, Ltd.(7.87%)等
美股SEC公告 ·  03/08 16:09
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息